Abstract:Arif Budiman, 1 Gracia Anastasya, 1 Annisa Luthfiyah Handini, 1 Ira Novianty Lestari, 2 Laila Subra, 3 Diah Lia Aulifa 2 1 Department of Pharmaceutics and Pharmaceutical Technology, Universitas Padjadjaran, Bandung, Indonesia; 2 Department of Pharmaceutical Analysis and Medicinal Chemistry, Universitas Padjadjaran, Bandung, Indonesia; 3 Department of Pharmacy, Universiti Geomatika Malaysia, Kuala Lumpur, Malaysia Correspondence: Diah Lia Aulifa, Department of Pharmaceutical Analysis and Medicinal Chemistry, Universitas Padjadjaran, Jl, Raya Bandung-Sumedang Km. 21, Bandung, 45363, Indonesia, Email Solid oral dosage forms are mostly preferred in pharmaceutical formulation development due to patient convenience, ease of product handling, high throughput, low manufacturing costs, with good physical and chemical stability. However, 70% of drug candidates have poor water solubility leading to compromised bioavailability. This phenomenon occurs because drug molecules are often absorbed after dissolving in gastrointestinal fluid. To address this limitation, delivery systems designed to improve the pharmacokinetics of drug molecules are needed to allow controlled release and target-specific delivery. Among various strategies, amorphous formulations show significantly high potential, particularly for molecules with solubility-limited dissolution rates. The ease of drug molecules to amorphized is known as their glass-forming ability (GFA). Specifically, drug molecules categorized into class III based on the Taylor classification have a low recrystallization tendency and high GFA after cooling, with substantial "glass stability" when heated. In the last decades, the application of mesoporous silica nanoparticles (MSNs) as drug delivery systems (DDS) has gained significant attention in various investigations and the pharmaceutical industry. This is attributed to the unique physicochemical properties of MSNs, including high loading capacity, recrystallization inhibition, excellent biocompatibility, and easy functionalization. Therefore, this study aimed to discuss the current state of good glass former drug loaded mesoporous silica and shows its impact on the pharmaceutical properties including dissolution and physical stability, along with in vivo study. The results show the importance of determining whether mesoporous structures are needed in amorphous formulations to improve the pharmaceutical properties of drug with a favorable GFA. Keywords: mesoporous silica nanoparticles, good glass-forming ability, characterization, dissolution, in vivo study Graphical Water solubility of drug is significantly important in drug development, as molecules absorption occurs after their dissolution in gastrointestinal fluids, directly impacting bioavailability. 1 In drug dosage development, oral solid dosage forms are often selected due to the ease of product handling, convenience for use, low manufacturing cost, with good physical, and chemical stability. 2 However, 75% of drug candidates are classified into Biopharmaceutics Classification System (BCS) classes II and IV. 3 This makes a delivery system essential, as 84% of drug products in the market still require a proper and absorption system for the treatment of diseases. 2 Amorphous formulations are increasingly becoming a popular method in drug discovery to enhance bioavailability, particularly for novel chemical entities with low water solubility. 4 This significant increase has led to the study focusing on converting API into amorphous forms. For instance, during melt extrusion, the formulation is heated, converting the crystalline API to a molten state, and cooling to a solid state. The API can become kinetically stuck in a disordered, amorphous state or pass through a liquid to a solid phase, reverting into its original or another crystalline form throughout the cooling process. Physical stability is a crucial factor during processing and storage, determining the suitability of the API for amorphous formulation. However, current knowledge regarding the tendency of organic molecules to form crystals after cooling from the undercooled melt state and its connection with the long-term physical stability of the resulting glass is rudimentary. This shows that understanding important physicochemical factors affecting crystallization tendency would help design dosage forms for new chemical entities. 5 A classification system of glass-forming ability (GFA) based on the recrystallization tendency of drug during cooling and heating cycles has previously been proposed. 5 GFA class (I) refers to drug that recrystallize during cooling of the melt at a rate of 20 K/min. Meanwhile, class (II) did not recr -Abstract Truncated-

Structural Features of the Glassy State and Their Impact on the Solid-State Properties of Organic Molecules in Pharmaceutical Systems

Glass transition, structural relaxation and stability of spray-dried amorphous food solids: A review

Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State

Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time

Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties

Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions

Physicochemical Investigations and Stability Studies of Amorphous Gliclazide

An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties

Crystal or Glass? Chemical and Crystallographic Factors in the Amorphization of Molecular Materials

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies

Mechanisms of dissolution and crystallization of amorphous glibenclamide

Characterization of the Time Scales of Molecular Motion in Pharmaceutically Important Glasses

Relationship between the Structure and Properties of Pharmaceutical Crystals

Implications of Low-concentration Polymer on the Physical Stability of Glassy Griseofulvin: Role of the Segmental Mobility

Nanostructures and Dynamics of Isochorically Confined Amorphous Drug Mediated by Cooling Rate, Interfacial, and Intermolecular Interactions.

Solid-solid Phase Transitions between Crystalline Polymorphs of Organic Materials

Polymorphism and Crystallization of Active Pharmaceutical Ingredients (APIs)

Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects

Theoretical model for the structural relaxation time in co-amorphous drugs

Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients